Helius Medical Technologies - Home

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

people2

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

Vice President, Strategy and Business Development

Dr. Brian Bapty has more than 14-years in capital markets, banking, sales and as an analyst covering biotechnology, drug development, healthcare and medical device sectors. Dr. Bapty served as Chief Executive Officer of NCP Northland Capital Partners Inc since 2009 and as President of Confederation Minerals Ltd. from March 16, 2012 to November 21, 2014. Prior to NCP, he served as Director of Research at Galileo Global Equity Advisors Inc and from April 2000 to February 2009, Dr. Bapty served as a Research Analyst at Raymond James Ltd., Research Division.

Dr. Bapty has served as an independent Bio-Medical Technology Consultant and has held positions as an Officer of several publicly traded companies. He has been an Independent Director of Eagle Graphite Incorporated since December 23, 2014. He has earned a Ph.D. in Experimental Medicine-Nephrology from the University of British Columbia. Dr. Bapty holds a B.Sc. degree in Cell and Developmental Biology from the University of British Columbia.